Profile: Neil Jenkins

Life Sciences

Biography: Life Sciences

Neil Jenkins is a partner in the London IP litigation practice group and the international life science sector group.

He gained a chemistry degree from Bristol University in 1984, joined the firm in 1986 and became a partner in 1996. His practice is focused on patent, trademark, copyright, design and trade secret litigation. It also encompasses IP-related regulatory work such as regulatory data exclusivity, supplementary protection certificates, labelling and advertising, as well as domain name disputes, brand management and anti-counterfeiting.

Neil has a particular interest and expertise in the management and conduct of cross-border patent litigation. His more high-profile Intellectual Property Office, Patents County Court, High Court, Court of Appeal and ECJ cases include PLG v Ardon (plastic grids), ICI v Montedison (polymer composite), HCC v BP (acetic acid purification), UCC v BP (fluid bed production of polyethylene), Stephenson v Du Pont (entitlement), Warner Lambert v Perfetti (Chloralit mark), Hesco v Maccaferri (gabions), Chef Revival v OHIM (Chef mark), Agilent v Waters (HPLC pumps), Teva v Merck (alendronate), Teva v Merck (simvastatin), Lundbeck v Niche (citalopram), Abbott v APS (clarithromycin), Celltech v OHIM (Celltech mark) and Actavis v Merck (finasteride).

Neil speaks regularly at IP conferences and contributes to the leading IP journals on many aspects of patent, trademark, copyright, design and trade secret law and litigation practice, as well as being the editor of International Intellectual Property Litigation (published by Butterworths) and sits on the editorial board of Patent World. He is a member of the IPO committee on international patent law and practice, the INTA parallel imports sub-committee and the CIPA litigation sub-committee.